ランセットの世界市場-2022-2029

市場の概要

ランセットの世界市場規模は、予測期間（2022-2029年）に11.66%のCAGRで成長すると予測されています。

ランセットは、プラスチックで被覆された外科用鋼の鋭い尖った部分であり、血液サンプルを得るために指（または他の身体部分）の皮膚を突き刺すために採用されています。また、腫れ物や膿瘍の排出のために小さな切開をするために使用されます。

市場力学

糖尿病や感染症の患者数の増加が、予測期間中のランセット市場の活性化につながっています。

糖尿病と感染症患者の増加が、予測期間中の世界のランセット市場の成長を後押ししています。

世界の糖尿病患者数の増加と感染症が、予測期間中のランセット世界市場の成長を加速させています。例えば、世界保健機関（WHO）の報告によると、結核は世界第13位の死亡理由であり、COVID-19に続く第2位の感染症です（ただしHIV/AIDSは上回っています）。WHOの報告によると、2020年には世界で約1,000万人が結核に感染し、そのうち約560万人が男性、約330万人が女性、約110万人が子どもであるとされています。TBFACTによる「結核統計」より。ORGでは、結核の影響が最も大きい30カ国で、2020年の新規患者の86％を占めました。インドが全体の3分の2を占め、次いで中国、インドネシア、フィリピン、パキスタン、ナイジェリア、バングラデシュ、南アフリカと続く

さらに、世界保健機関（WHO）世界結核報告書によると、2021年の結核患者数は、世界保健機関（WHO）地域の欧州（2.3%）、アメリカ（3.0%）、東地中海（8.3%）で少なく、西太平洋（18%）、アフリカ（25%）、東南アジア（43%）で多いことが分かっています。同様に、世界保健機関（WHO）のデータによると、サハラ以南のアフリカは引き続きマラリアの負担を負い、患者の約95％、死亡者の約96％を占めています。したがって、感染症の増加例が高い市場成長を後押しすると予想されます。

皮膚を刺さずに血液パラメータを測定できる高度な製品の導入は、世界のランセット市場の成長に対する大きな脅威となっています。

しかし、皮膚を刺さずに血液パラメータを提供できる新製品を開発することは、世界のランセット市場にとって大きな脅威となっています。例えば、アボット社のFreeStyle Libreは、指を刺さずにグルコース値を把握することができる画期的な製品です。これは、リーダーとセンサーを搭載したセンサーベースのグルコースモニタリングシステムです。

COVID-19の影響。

COVID-19の大流行が、世界のランセット市場に大きな影響を与えました。血液中の抗体を調べるCOVID-19抗体検査や血清検査を行うためのランセットへの需要が高まっています。COVID-19の抗体検査を行うには、通常、医療従事者が、ランセットで指を刺したり、静脈から採血したりして血液サンプルを採取します。多くの人々がCOVID-19に感染したため、血清検査とそれに伴うランセットに対する大きな需要が生まれ、世界のランセット市場にプラスの影響を及ぼしているのです。

目次

第1章 調査手法と調査範囲

• 調査手法
• 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 市場影響要因
  • 促進要因
    • 感染症患者の増加
    • 糖尿病患者の増加
  • 抑制要因
    • 代替製品の発売
  • ビジネスチャンス
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 規制分析

第6章 COVID-19の分析

• COVID-19の市場分析
  • COVID-19以前の市場シナリオ
  • COVID-19の現在の市場シナリオ
  • COVID-19の後、または将来のシナリオ
• COVID-19の中での価格ダイナミクス
• 需要-供給スペクトラム
• パンデミック時の市場に関連する政府の取り組み
• メーカーの戦略的取り組み
• まとめ

第7章 タイプ別

• パーソナルランセット
• セイフティランセット
  • サイドボタンランセット
  • プッシュボタンランセット
  • 圧力式ランセット
  • その他

第8章 アプリケーション別

• ヘモグロビン検査
• グルコース検査
• 凝固検査
• その他

第9章 エンドユーザー別

• 病院・クリニック
• 在宅医療
• 診断センター・病理検査室
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ地域

第11章 競合情勢

• 主な展開と戦略
• 企業シェア分析
• 製品ベンチマーク

第12章 企業プロファイル

• Abbott Laboratories
  • 企業概要
  • 製品ポートフォリオと説明
  • 主なハイライト
  • 財務概要
• B. Braun Melsungen
• BD
• Roche Diagnostics
• HTL-Strefa S.A
• Intuity Medical
• Terumo Corporation
• Medline Industries
• Arkray
• Owen Mumford

第13章 DataM

Market Overview

The global lancets market size was valued around US$ YY million in 2021 and is expected to reach US$ YY million by 2029, growing at a CAGR of 11.66% during the forecast period (2022-2029).

A lancet is a sharp pointy piece of surgical steel sheathed in plastic, employed to pierce the skin on one's finger (or other body parts) to get a blood sample. Other lancets are used for making small incisions, as in the draining of boils and abscesses.

Market Dynamics

The growing number of diabetes cases and infectious diseases are fueling the global lancets market in the forecast period.

Growing diabetes and infectious disease cases are boosting the global lancet market growth during the forecast period.

The growing number of diabetes cases and infectious diseases worldwide are accelerating the global lancets market growth during the forecast period. For instance, according to the World Health Organization(WHO) report, Tuberculosis is the world's 13th leading reason of death and the second leading infectious disease, following only COVID-19 (but ahead of HIV/AIDS). Around 10 million people suffered from Tuberculosis globally in 2020, according to the WHO report, including around 5.6 million men, 3.3 million women, and 1.1 million children. From the TB Statistics by TBFACT. ORG, the 30 most-affected countries by Tuberculosis, accounted for 86% of new cases in 2020. India had two-thirds of the total, followed by China, Indonesia, the Philippines, Pakistan, Nigeria, Bangladesh, and South Africa

Moreover, according to the World Health Organization Global Tuberculosis Report, the lesser of tuberculosis cases were in the World Health Organization (WHO) regions of Europe (2.3%), the Americas (3.0%), Eastern Mediterranean (8.3%) and the majority numbers of tuberculosis cases were found in Western Pacific (18%), Africa (25%) and South-East Asia (43%) for 2021. Likewise, according to World Health Organization (WHO) data, Sub-Saharan Africa continued to bear the burden of malaria, accounting for around 95% of cases and 96% of deaths. Therefore, the climbing cases of infectious diseases are anticipated to boost the high market growth.

Introducing advanced products that can measure blood parameters without pricking skin is a major threat to the global lancets market growth.

However, developing new products that can provide the blood parameters without pricking is a major threat to the global lancet market. For instance, Abbott's FreeStyle Libre is a revolutionary product that helps to track glucose levels without fingerpicks. It is a sensor-based glucose monitoring system with a reader and a sensor.

COVID-19 Impact.

The COVID-19 pandemic has impacted the global lancets market significantly. There was an increased demand for the lancets to perform COVID-19 Antibody or serology tests which look for antibodies in the blood. For conducting an antibody test for COVID-19, a healthcare professional normally withdraws a blood sample, commonly by a finger prick with a lancet or drawing blood from a vein. Then the sample is tested to determine whether it contains antibodies against the COVID-19 virus since a large population was infected with COVID-19, creating a great demand for serological testing and thereby lancets, positively impacting the global lancets market.

Segment Analysis

The blood glucose testing segment is estimated to dominate the market throughout the forecast period (2022-2029).

The blood glucose testing segment is predicted to grow at the highest CAGR during the forecast period (2022-2029). Owing to the rising cases of diabetes globally, for instance, according to the International Diabetic Federation statistics from 2021, approximately 537 million adults (20-79 years) are living with diabetes, and the number is presumed to attain around 643 million by 2030. It will be about 783 million by 2045. Currently, 3 out of 4 adults from low- and middle-income countries have diabetes. Still, around 1 in 2, accounting for about 240 million adults living with diabetes, are undiagnosed. Diabetes claimed about 6.7 million deaths and USD 966 billion in health expenditure, 9% of total spending on adults. Also, 541 million adults are at increased risk of developing type 2 diabetes.

Furthermore, growing awareness about diabetes contributes to the growth of the glucose testing segment at a high CAGR, as many government and non-government organizations are working to spread awareness about diabetes and the benefits of regular blood glucose level monitoring. Therefore, from the above mention data and supporting statistics, it is anticipated that the blood glucose testing segment will dominate the global lancet market throughout the forecast period (2022-2029).

Geographical Analysis

The North American region holds the largest global lancets market share.

North America holds most of the lancet market. It is presumed to show a similar trend in the forecasted years (2022-2029), Owing to the steps taken by the government addressing diabetes and the growing cases of diabetes in this region. For instance, according to the Proclamation on National Diabetes by THE WHITE HOUSE in OCTOBER 2022, In August, after decades of big pharmaceutical companies blocking meaningful change, the president of the United States signed the Inflation Reduction Act into law, which caps the cost of a month's supply of insulin at $35 per prescription for over 3 million seniors on Medicare. Moreover, congress has significantly expanded its backing of diabetes-related biomedical research, specifically at the National Institutes of Health. For example, a controlled trial of glucose control in type 1 diabetes demonstrated the effectiveness of blood sugar control in preventing eye, kidney, and nerve complications. Diabetic Retinopathy Study and the Early Treatment Diabetic Retinopathy Study demonstrated the value of laser photocoagulation to prevent the progression of diabetic eye disease and establish diabetes research and training centers across the country.

Furthermore, according to the International Diabetes Federation, North America and Caribbean Region had 51 million adults (20-79) with diabetes in 2021, and it is predicted to be 57 million by 2030 and 63 million by 2045. Around 12 million people with diabetes are undiagnosed. Thus, the above data indicate that North America will hold most of the lancet market throughout the forecast period.

Competitive Landscape

The lancets market is moderately competitive due to opportunities for new market players to enter. Some of the key players hold the majority of the market share. Some key players are Abbott Laboratories, B. Braun Melsungen, BD, Roche Diagnostics, HTL-Strefa S.A, Intuity Medical, Terumo Corporation, Medline Industries, Arkray and Owen Mumford. These key players hold the major share of the market through various market tactics such as innovations, product launches, collaborations, acquisitions, and alliances. For instance, in October 2021, Roche Diabetic Care collaborated with Zur Rose, a European digital healthcare ecosystem provider, to improve day-to-day therapy management and address the requirements of 60 million European diabetic patients.

Abbott Diabetic Care

Overview:

Abbott Diabetic Care, a global leader in diabetes care, was founded in 1995 and had since been constantly working to deliver the highest quality products and unwavering support to our customers.

Product Portfolio:

Abbott Diabetic Care's product portfolio contains FREESTYLE LANCETS: FreeStyle Lancets are constructed from thin, 28 gauge, sterilized stainless steel that provides a secure lancing experience. For use with FreeStyle Lancing Device I or II and conforms to almost all other lancing devices.

The global lancets market report would provide access to approximately 40 + market data tables, 45 + figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Growing Cases of Infectious Diseases
    • 4.1.1.2. Growing Cases of Diabetes
  • 4.1.2. Restraints
    • 4.1.2.1. Substituent Product Launches
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturer's Strategic Initiatives
• 6.6. Conclusion

7. By Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 7.1.2. Market Attractiveness Index, By Type
• 7.2. Personal Lancets
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 7.3. Safety Lancets
  • 7.3.1. Side Button Lancets
  • 7.3.2. Push Button Lancets
  • 7.3.3. Pressure Activated Lancets
  • 7.3.4. Others

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Hemoglobin Testing
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 8.3. Glucose Testing
• 8.4. Coagulation Testing
• 8.5. Others

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Hospitals & Clinics
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 9.3. Home Care
• 9.4. Diagnostic Centers and Pathology Laboratories
• 9.5. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. U.K.
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

• 11.1. Key Developments and Strategies
• 11.2. Company Share Analysis
• 11.3. Product Benchmarking

12. Company Profiles

• 12.1. Abbott Laboratories
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Key Highlights
  • 12.1.4. Financial Overview
• 12.2. B. Braun Melsungen
• 12.3. BD
• 12.4. Roche Diagnostics
• 12.5. HTL-Strefa S.A
• 12.6. Intuity Medical
• 12.7. Terumo Corporation
• 12.8. Medline Industries
• 12.9. Arkray
• 12.10. Owen Mumford

LIST NOT EXHAUSTIVE

13. DataM

• 13.1. Appendix
• 13.2. About Us and Services
• 13.3. Contact Us